videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          id
        }
      }
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    title
    slug
    lang
    htmlBody
    ... on Video {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    id
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

first

order

upcoming

edges

CEO, Sweden

Claus Thestrup

Ascelia Pharma

Meet and ask questions to Deputy CEO Julie Waras Brogren from Ascelia Pharma on 19 August 2024 at 2:30 PM CEST.

During Q2 Ascelia Pharma announced very strong headline data from the Orviglance phase 3 study and draws down the second tranche on the existing loan facility with Fenja Capital. After the quarter closed the company announced a planned rights issue of gross SEK 105 mio.

You can already now sign up for the event and send in your questions. You don&#x2019;t have to participate live to send in questions for the event. Meet and ask questions to Deputy CEO Julie Waras Brogren from Ascelia Pharma on 19 August 2024 at 2:30 PM CEST. During Q2 Ascelia Pharma announced very strong headline data from the Orviglance phase 3 study and draws down the second tranche on the existing loan facility with Fenja Capital. After the quarter closed the company announced a planned rights issue of gross SEK 105 mio. Ascelia Pharma is a biotech company focused on orphan oncology treatments. Ascelia Pharma develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates &#x2013; Orviglance&#xae; (Mangoral) and Oncoral &#x2013; in clinical development. Ascelia Pharma has its global headquarters in Malm&#xf6;, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE) Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 11 July 11.41 AM.

HC Andersen Capital

Ascelia Pharma - Update on Q2 2024 and rights issue

Wetteri

Wetteri Q3'24: Uusien autojen myynti historiallisen vaimeaa

Audientes

Audientes – Presentation of Q3 2024 report

Wetteri, Webcast, Q3'24

WithSecure

WithSecuren sijoittajapäivä 22.11.2024

Buffett keventää, sisäpiirin ostotarjoukset ja indeksisijoittaminen | Raharadio – jakso 2

Pysy ajantasalla Inderesin uutiskirjeillä